Dr. Lal PathLabs Ltd - 539524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure Attached09-04-2024
09-04-2024
Dr. Lal PathLabs Ltd - 539524 - Received Assessment Order Issued By Income Tax Department
Received Assessment Order issued by Income Tax Department01-04-2024
Dr Lal PathLabs jumps 5% on double upgrade from Kotak Institutional Equities
Dr Lal PathLabs shares were trading at Rs 2,234.65, up nearly 5 percent from the previous close. The revised price target implies an upside of 8 percent from March 22 closing26-03-2024
Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
Intimation of Closure of Trading Window26-03-2024
Dr. Lal PathLabs Ltd - 539524 - Received An Assessment Order And Demand Notice Issued By Income Tax Department
Disclosure attached under Regulation 30 of SEBI (LODR), 201520-03-2024
Dr. Lal PathLabs Ltd - 539524 - Received An Assessment Order And Demand Notice Issued By Income Tax Department
Disclosure attached under Regulation 30 of SEBI (LODR), 201518-03-2024
Dr. Lal PathLabs Ltd - 539524 - Appointment Of Chief Executive Officer (Key Managerial Personnel)
Appointment of Chief Executive Officer (KMP)17-03-2024
Dr. Lal PathLabs Ltd - 539524 - Change In Authorized Persons For The Purpose Of Determining Materiality Of Any Event Or Information Pursuant To Regulation 30(5) Of SEBI (LODR), 2015
Change in authorized persons for the purpose of determining materiality of any event or information, which shall be effective from May 21, 202417-03-2024
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Appointment Of Chief Executive Officer (Key Managerial Personnel)
Based on recommendations of Nomination & Remuneration Committee, the Board of Directors in their meeting held today i.e., March 17, 2024, inter-alia, approved the re-designation of Mr. Shankha Banerjee by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) with effect from May 21, 202417-03-2024